Skip to main content
Guerbet logo

Guerbet — Investor Relations & Filings

Ticker · GBT ISIN · FR0000032526 LEI · 969500WV1U1WQ059L135 PA Manufacturing
Open in API
Filings indexed 623 across all filing types
Latest filing 2012-07-27 Earnings Release
Country FR France
Listing PA GBT

About Guerbet

https://www.guerbet.com

Guerbet is a global specialist in medical imaging, offering a comprehensive range of solutions and services for diagnostic and interventional procedures. The company develops and manufactures contrast media, medical devices such as injectors, and related software for X-ray, Magnetic Resonance Imaging (MRI), and Interventional Imaging. With a history of innovation dating back to 1926, Guerbet focuses on providing healthcare professionals with tools to enhance diagnostic accuracy and improve patient care. Its portfolio is designed to support a wide array of clinical applications, from initial diagnosis to treatment monitoring.

Recent filings

Filing Released Lang Actions
Guerbet - Résultats du 1er semestre 2012
Earnings Release Classification · 98% confidence The document is titled 'COMMUNIQUE DE PRESSE' (Press Release) and presents summarized consolidated financial figures (Chiffre d'affaires, Résultat opérationnel, Résultat net) for the first semester of 2012 compared to 2011. It discusses key performance indicators, operational highlights, and future outlook ('Perspectives sur l'année'). This structure—a brief, high-level summary of period results released before a full report—is characteristic of an Earnings Release (ER). It is not a full Annual Report (10-K) or a comprehensive Interim Report (IR), as it only covers the first half-year results in summary form and explicitly points to a future communication for Q3 results. The document length (under 5,000 characters) also suggests it is an announcement rather than the full detailed report. H1 2012
2012-07-27 French
Guerbet - 2012 First-Half Results
Earnings Release Classification · 98% confidence The document is dated July 27, 2012, and presents consolidated financial data for 'H1 2012' (First Half 2012) compared to H1 2011, including Revenue, Operating Income, and Net Income. It is explicitly titled 'PRESS RELEASE' and summarizes key financial highlights and provides a full-year outlook. This structure—a brief announcement of period results with key figures and commentary, rather than the full, detailed report—is characteristic of an Earnings Release (ER). It is too brief and summary-focused to be a comprehensive Interim Report (IR) or Annual Report (10-K). The mention of an upcoming Q3 sales publication further confirms its nature as a periodic results announcement. H1 2012
2012-07-27 English
Guerbet affiche de nouvelles ambitions en imagerie médicale
Regulatory Filings Classification · 86% confidence The document is titled 'INFORMATION PRESSE' (Press Information) and announces the inauguration of a new production unit and outlines the company's growth strategy and investment figures. It is dated July 3, 2012, and provides general company background ('A propos de Guerbet'). This format strongly suggests a press release or news announcement regarding operational updates and strategic direction, rather than a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial report (IR, AR). Since it is an announcement about company operations and strategy, and does not fit the specific categories like M&A (TAR), Capital Change (CAP), or Dividend (DIV), the most appropriate general category for a significant, non-standard corporate announcement that isn't a formal financial report is 'Regulatory Filings' (RNS) as a fallback, or potentially a general 'Information' category if one existed. Given the provided options, RNS serves as the best fit for a general corporate press release that doesn't map directly to the other specific financial or governance reports. However, since it is a strategic operational update, it is often classified separately. Reviewing the definitions, none perfectly capture a strategic press release about facility expansion. Given the options, RNS (Regulatory Filings / miscellaneous announcements) is the closest fit for a non-standard, non-financial report announcement.
2012-07-03 French
Guerbet reveals new ambitions for medical imaging
Regulatory Filings Classification · 95% confidence The document is explicitly titled 'PRESS RELEASE' and details a specific corporate event: the inauguration of a new production unit and associated investment/growth strategy updates. This type of announcement, focusing on operational milestones, capacity expansion, and strategic direction rather than periodic financial results (like 10-K or ER) or mandatory regulatory filings, is best classified as a general corporate announcement. Since it does not fit the specific categories like M&A (TAR), Director's Dealing (DIRS), or Dividend Notice (DIV), and it is not a transcript (CT) or a formal investor presentation (IP), the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous corporate news releases that are not covered by more specific codes. The length (4544 chars) is substantial enough that it is not just a brief notification of a report being available (RPA).
2012-07-03 English
Guerbet - Déclaration relative au nombre d'actions et de droits de vote au 30 Juin 2012
Share Issue/Capital Change Classification · 95% confidence The document is a press release dated July 2, 2012, titled "DECLARATION RELATIVE AU NOMBRE D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL DE LA SOCIETE" (Declaration relative to the number of shares and voting rights comprising the company's capital). It explicitly states it is published in application of the French Commercial Code (L. 233-8 II) and AMF regulations (article 222-12-5), requiring monthly publication of the total number of voting rights and shares if they have changed. The content is a table detailing the total shares, treasury shares, theoretical voting rights, and exercisable voting rights as of June 30, 2012. This specific type of mandatory disclosure regarding the total number of voting rights and shares outstanding fits best under the category for official results from shareholder votes or capital structure announcements, but given the specific nature of reporting total voting rights, it aligns closely with regulatory reporting concerning capital structure and voting power. Among the provided codes, 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is the most precise fit for a formal declaration of the total number of voting rights, even though it's a monthly update rather than post-meeting results. It is a formal regulatory disclosure about voting rights.
2012-07-02 French
Guerbet - Déclaration relative au nombre d'actions et de droits de vote au 31 Mai 2012
Share Issue/Capital Change Classification · 95% confidence The document is titled "DECLARATION RELATIVE AU NOMBRE D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL DE LA SOCIETE" (Declaration relative to the number of shares and voting rights comprising the company's capital). It explicitly references French commercial code (L. 233-8 II) and AMF regulations (article 222-12-5), stating that companies must publish the total number of voting rights and shares monthly if they have changed. The content is a table showing the share count and voting rights as of May 31, 2012. This type of mandatory monthly disclosure regarding the capital structure and voting rights aligns most closely with regulatory reporting requirements that are not covered by the primary annual (10-K) or interim (IR) reports. Since it is a specific regulatory disclosure about capital structure changes (or confirmation of the current structure), it fits best under the general 'Regulatory Filings' category (RNS) as a specific, recurring regulatory announcement, although it touches upon capital structure. However, given the specific nature of reporting voting rights and share capital changes, it is a distinct regulatory filing. It is not a dividend announcement (DIV), a share issue (SHA), or a transaction in own shares (POS), but rather a mandatory disclosure of the total voting base. RNS is the most appropriate fallback for specific, non-standard regulatory disclosures.
2012-06-01 French

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.